Revenue | ₹537.55Cr |
Net Profits | ₹55.83Cr |
Net Profit Margins | 10.39% |
Astrazeneca Pharma India Ltd’s revenue jumped 35.79% since last year same period to ₹537.55Cr in the Q1 2025-2026. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated 8.24% jump in its revenue since last 3-months.
Astrazeneca Pharma India Ltd’s net profit jumped 573.54% since last year same period to ₹55.83Cr in the Q1 2025-2026. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated -4.15% fall in its net profits since last 3-months.
Astrazeneca Pharma India Ltd’s net profit margin jumped 448.73% since last year same period to 10.39% in the Q1 2025-2026. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated -11.45% fall in its net profit margins since last 3-months.
The revenue for Astrazeneca Pharma India Ltd in the Q1 results 2025 was ₹537.55Cr.
The net profit for Astrazeneca Pharma India Ltd in the Q1 results 2025 was ₹55.83Cr.
The net profit margin for Astrazeneca Pharma India Ltd in the Q1 results 2025 was 10.39%.
The revenue for Astrazeneca Pharma India Ltd in the Q1 results 2024 was ₹395.87Cr.
The net profit for Astrazeneca Pharma India Ltd in the Q1 results 2024 was ₹-11.79Cr.
The net profit margin for Astrazeneca Pharma India Ltd in the Q1 results 2024 was -2.98%.